Clinical trial
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
NCT00004285 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00004285 |
|---|---|
| Title | Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis |
| Official title | Randomized Study of Standard vs High Amount of Hemodialysis Using Low vs High Flux Dialyzer Membranes for End Stage Renal Disease |
| Acronym | HEMO |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | University of Rochester The Cleveland Clinic Tufts Medical Center Vanderbilt University Icahn School of Medicine at Mount Sinai Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical… |
| Status | Completed |
| Study type | Interventional |
| Conditions | End Stage Renal Disease |
| Intervention type | Device |
| Interventions | Standard dose, low flux hemodialysis, high flux hemodialysis, High dose |
| Enrollment | 1,846 |
| Start date | Mar 1, 1995 |
| Primary completion | Dec 31, 2001 |
| Completion | Dec 31, 2001 |
| First posted | Oct 19, 1999 |
| Last update posted | Sep 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: